Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function.

Gomes I, Gupta A, Bushlin I, Devi LA.

Front Pharmacol. 2014 Dec 3;5:268. doi: 10.3389/fphar.2014.00268. eCollection 2014. Review.

2.

Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain.

Bushlin I, Gupta A, Stockton SD Jr, Miller LK, Devi LA.

PLoS One. 2012;7(12):e49789. doi: 10.1371/journal.pone.0049789. Epub 2012 Dec 14.

3.

Reduction of AP180 and CALM produces defects in synaptic vesicle size and density.

Petralia RS, Wang YX, Indig FE, Bushlin I, Wu F, Mattson MP, Yao PJ.

Neuromolecular Med. 2013 Mar;15(1):49-60. doi: 10.1007/s12017-012-8194-x. Epub 2012 Aug 1.

4.

Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons.

Rozenfeld R, Bushlin I, Gomes I, Tzavaras N, Gupta A, Neves S, Battini L, Gusella GL, Lachmann A, Ma'ayan A, Blitzer RD, Devi LA.

PLoS One. 2012;7(1):e29239. doi: 10.1371/journal.pone.0029239. Epub 2012 Jan 3.

5.

Role of antibodies in developing drugs that target G-protein-coupled receptor dimers.

Hipser C, Bushlin I, Gupta A, Gomes I, Devi LA.

Mt Sinai J Med. 2010 Jul-Aug;77(4):374-80. doi: 10.1002/msj.20199. Review.

6.

Increased abundance of opioid receptor heteromers after chronic morphine administration.

Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, Lim M, Maillet E, Junek M, Cahill CM, Harkany T, Devi LA.

Sci Signal. 2010 Jul 20;3(131):ra54. doi: 10.1126/scisignal.2000807.

7.

Quantitative neuroproteomics of the synapse.

Ramos-Ortolaza DL, Bushlin I, Abul-Husn N, Annangudi SP, Sweedler J, Devi LA.

Methods Mol Biol. 2010;615:227-46. doi: 10.1007/978-1-60761-535-4_18.

8.

Cannabinoid-opioid interactions during neuropathic pain and analgesia.

Bushlin I, Rozenfeld R, Devi LA.

Curr Opin Pharmacol. 2010 Feb;10(1):80-6. doi: 10.1016/j.coph.2009.09.009. Epub 2009 Oct 25. Review.

9.

Systems approach to explore components and interactions in the presynapse.

Abul-Husn NS, Bushlin I, MorĂ³n JA, Jenkins SL, Dolios G, Wang R, Iyengar R, Ma'ayan A, Devi LA.

Proteomics. 2009 Jun;9(12):3303-15. doi: 10.1002/pmic.200800767.

10.

Clathrin assembly protein AP180 and CALM differentially control axogenesis and dendrite outgrowth in embryonic hippocampal neurons.

Bushlin I, Petralia RS, Wu F, Harel A, Mughal MR, Mattson MP, Yao PJ.

J Neurosci. 2008 Oct 8;28(41):10257-71. doi: 10.1523/JNEUROSCI.2471-08.2008.

11.

Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells.

Furukawa K, Matsuzaki-Kobayashi M, Hasegawa T, Kikuchi A, Sugeno N, Itoyama Y, Wang Y, Yao PJ, Bushlin I, Takeda A.

J Neurochem. 2006 May;97(4):1071-7. Epub 2006 Apr 5.

12.

Partially overlapping distribution of epsin1 and HIP1 at the synapse: analysis by immunoelectron microscopy.

Yao PJ, Bushlin I, Petralia RS.

J Comp Neurol. 2006 Jan 10;494(2):368-79.

PMID:
16320245
13.

Preserved synaptic vesicle recycling in hippocampal neurons in a mouse Alzheimer's disease model.

Yao PJ, Bushlin I, Furukawa K.

Biochem Biophys Res Commun. 2005 Apr 29;330(1):34-8.

PMID:
15781228
14.

Synaptic distribution of the endocytic accessory proteins AP180 and CALM.

Yao PJ, Petralia RS, Bushlin I, Wang Y, Furukawa K.

J Comp Neurol. 2005 Jan 3;481(1):58-69.

PMID:
15558718

Supplemental Content

Loading ...
Support Center